Northrop Grumman Corp

NOC remains entrenched in a Stage 4 decline, with sequential lower highs and lower lows under declining short-term EMAs and the 50 DMA. Recent relief rallies, including the Bullish Pivot Point mean-reversion attempt, have failed at the resisting 9/21 EMA cluster, reinforcing the bearish medium-term tradable side. Execution favors selling into these failed rallies around the EMA zone with a Sell Now posture.

• ↑Q1 sales $9.9B (+4% YoY) with segment margins at 10.8%.
• ↑Record $96B backlog indicates strong multi-year revenue pipeline.
• ↓B-21 program incurred $477M pre-tax loss, pressuring margins.